2015
DOI: 10.1128/jcm.00442-15
|View full text |Cite
|
Sign up to set email alerts
|

First Case Report of Campylobacter volucris Bacteremia in an Immunocompromised Patient

Abstract: bWe report a case of Campylobacter volucris bacteremia in an immunocompromised patient with polycythemia vera and alcoholic liver cirrhosis. To our knowledge, this is the first case report in which this organism has been isolated from a human clinical specimen. CASE REPORTA 75-year-old male patient visited the Chung-Ang University Hospital with a chief complaint of abdominal discomfort due to accumulation of ascites fluid. The abdomen was diffusely distended without tenderness or rebound tenderness. The patien… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 23 publications
0
7
0
Order By: Relevance
“…61,62 Additionally, carbapenems were successfully used to treat Campylobacter-associated bacteremia and sepsis and were suggested as an alternative antibiotic for Campylobacter-associated systemic infections. 63,64 Concerned with the rising resistance to fluoroquinolone and macrolide in Campylobacter, some investigators proposed the use of the amoxicillin-clavulanic acid combination as an alternative antibiotic therapy for campylobacteriosis. 18,65 This proposition was supported by the evidence that Campylobacter isolates from pediatric patients and international travelers were uniformly susceptible to amoxicillin-clavulanic acid based on in vitro susceptibility tests.…”
Section: Antibiotic Resistance and Alternative Antibiotic Therapymentioning
confidence: 99%
“…61,62 Additionally, carbapenems were successfully used to treat Campylobacter-associated bacteremia and sepsis and were suggested as an alternative antibiotic for Campylobacter-associated systemic infections. 63,64 Concerned with the rising resistance to fluoroquinolone and macrolide in Campylobacter, some investigators proposed the use of the amoxicillin-clavulanic acid combination as an alternative antibiotic therapy for campylobacteriosis. 18,65 This proposition was supported by the evidence that Campylobacter isolates from pediatric patients and international travelers were uniformly susceptible to amoxicillin-clavulanic acid based on in vitro susceptibility tests.…”
Section: Antibiotic Resistance and Alternative Antibiotic Therapymentioning
confidence: 99%
“…These bacteria are typically isolated from coastal regions, marine environments, molluscs, and aquatic birds and mammals. However, the sporadic isolation of C. lari and related taxa from human infections (86)(87)(88)(89) highlights their potential as emerging pathogens.…”
Section: Campylobacter Lari and Related Taxamentioning
confidence: 99%
“…At the time of writing this paper, the genus Campylobacter comprised 32 species and 13 subspecies with validly published names 1 . Twenty Campylobacter species have been isolated from symptomatic or healthy humans: C. coli , C. concisus , C. curvus , C. fetus , C. gracilis , C. helveticus , C. hominis , C. hyointestinalis , C. insulaenigrae , C. jejuni , C. lanienae , C. lari , C. mucosalis , C. peloridis , C. rectus , C. showae , C. sputorum , C. upsaliensis , C. ureolyticus and C. volucris ( Man, 2011 ; Kweon et al, 2015 ). Some of these Campylobacter species have also been isolated from the gastrointestinal tract of animals, mainly farm animals (poultry, pigs, cattle, and sheep), where Campylobacter spp.…”
Section: Introductionmentioning
confidence: 99%